An Open-Label Long-Term Phase 3 Study of CAM2029, an Octreotide Subcutaneous Depot, in Patients with Acromegaly (ACROINNOVA 2): Interim Analysis of Patient-Reported Outcomes
Endocrine Abstracts(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined